| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Myron S. Cohen | Q16733099 |
| Barton Haynes | Q4865631 | ||
| George M. Shaw | Q78514357 | ||
| Andrew James McMichael | Q21165187 | ||
| P2860 | cites work | A controlled study of the effectiveness of public health HIV partner notification services | Q82808293 |
| Antiretroviral Therapy as HIV Prevention: Status and Prospects | Q84774188 | ||
| Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention | Q21245029 | ||
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract | Q22242981 | ||
| HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells | Q22251066 | ||
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men | Q24612082 | ||
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Q24629582 | ||
| Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections | Q27488278 | ||
| Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS | Q28215577 | ||
| Male circumcision for HIV prevention: current research and programmatic issues | Q28297402 | ||
| The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | Q29417018 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
| Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
| Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Targeting early infection to prevent HIV-1 mucosal transmission. | Q30386549 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection | Q33576664 | ||
| High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. | Q33582135 | ||
| Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control | Q33594461 | ||
| Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing | Q33680395 | ||
| Wide variation in the multiplicity of HIV-1 infection among injection drug users | Q33877419 | ||
| Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection | Q33877481 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Role of the primary infection in epidemics of HIV infection in gay cohorts. | Q34323784 | ||
| Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. | Q34434854 | ||
| Induction of immunity to human immunodeficiency virus type-1 by vaccination | Q34540645 | ||
| B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy | Q34541705 | ||
| The mucosal barrier and immune activation in HIV pathogenesis | Q34606638 | ||
| Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel | Q37773748 | ||
| Clinical management of acute HIV infection: best practice remains unknown | Q37789343 | ||
| Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification | Q38417936 | ||
| HIV-1 transmission, by stage of infection | Q38875941 | ||
| Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda | Q38881073 | ||
| High rates of forward transmission events after acute/early HIV-1 infection | Q39788342 | ||
| Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design | Q41338220 | ||
| Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection | Q43108142 | ||
| Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys | Q43212235 | ||
| HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity | Q43438499 | ||
| The role of early HIV infection in the spread of HIV through populations | Q43565729 | ||
| The effect of pair formation and variable infectivity on the spread of an infection without recovery. | Q43787375 | ||
| No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa | Q44773899 | ||
| Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening | Q45397816 | ||
| Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus | Q45404246 | ||
| Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection | Q45738778 | ||
| A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia | Q45871436 | ||
| Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase | Q46843159 | ||
| HIV evolution: CTL escape mutation and reversion after transmission | Q47211742 | ||
| Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. | Q47431117 | ||
| Evaluating the impact of antiretroviral therapy on HIV transmission. | Q51872027 | ||
| Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. | Q51989833 | ||
| Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. | Q51993308 | ||
| Modelling the natural history of HIV infection in individuals and its epidemiological implications. | Q52050903 | ||
| Reduction of HIV concentration during acute infection: independence from a specific immune response. | Q52312556 | ||
| Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells | Q57075707 | ||
| Amplified HIV Transmission during Early‐Stage Infection | Q57096881 | ||
| State of the art for diagnosis of HIV infection | Q64127195 | ||
| Implications of increased infectivity in early-stage HIV infection. Application of a Bernoulli-process model of HIV transmission | Q77178020 | ||
| Rethinking prevention of HIV type 1 infection | Q34767070 | ||
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia | Q34848486 | ||
| HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection | Q34952914 | ||
| Is developing an HIV-1 vaccine possible? | Q35043547 | ||
| Role of acute and early HIV infection in the sexual transmission of HIV. | Q35087462 | ||
| HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention | Q35515137 | ||
| Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Q35830147 | ||
| The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students | Q36081464 | ||
| Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection | Q36225040 | ||
| Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes | Q36229197 | ||
| HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy | Q36401419 | ||
| Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention | Q36490642 | ||
| Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis | Q36597028 | ||
| How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission? | Q36649584 | ||
| Current concepts in AIDS pathogenesis: insights from the SIV/macaque model | Q36705227 | ||
| HIV's vagina travelogue | Q36739040 | ||
| Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. | Q36793483 | ||
| New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma | Q36891848 | ||
| Setting the stage: host invasion by HIV. | Q36983857 | ||
| Probability of HIV transmission during acute infection in Rakai, Uganda | Q37037595 | ||
| Primary HIV infection: to treat or not to treat? | Q37056097 | ||
| High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection | Q37127899 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Innate immune responses in primary HIV-1 infection. | Q37227226 | ||
| Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay | Q37347026 | ||
| Modeling sequence evolution in acute HIV-1 infection | Q37384535 | ||
| Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. | Q37390603 | ||
| The challenge of finding a cure for HIV infection | Q37407598 | ||
| The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. | Q37428017 | ||
| Clinical presentation and diagnosis of primary HIV-1 infection | Q37447472 | ||
| Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection | Q37682617 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 1943-1954 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Acute HIV-1 Infection | |
| P478 | volume | 364 |
| Q47214980 | A Cohort Approach to Real Time Detection of Acute HIV infections among People who Inject Drugs in St. Petersburg, Russia |
| Q52355341 | A Lachnospiraceae-dominated bacterial signature in the fecal microbiota of HIV-infected individuals from Colombia, South America. |
| Q90311897 | A longitudinal study of the relationship between intimate partner violence and postpartum unsafe sex among newly diagnosed HIV-infected South African women |
| Q36893217 | A novel acute HIV infection staging system based on 4th generation immunoassay |
| Q38853281 | A penalized regression approach to haplotype reconstruction of viral populations arising in early HIV/SIV infection |
| Q57706204 | A signature for biological heterogeneity in susceptibility to HIV infection? |
| Q34731350 | A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection |
| Q57175535 | A study on the dynamics of temporary HIV treatment to assess the controversial outcomes of clinical trials: An in-silico approach |
| Q87909390 | Abstracts of the HIV & Hepatitis in the Americas 2017 - Congress |
| Q64229332 | Acute HIV Infection in Youth: Protocol for the Adolescent Trials Network 147 (ATN147) Comprehensive Adolescent Research and Engagement Studies (CARES) Study |
| Q38686941 | Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok |
| Q40503118 | Acute HIV infection transmission among people who inject drugs in a mature epidemic setting |
| Q93367223 | Adjustment to acute or early HIV-1 infection diagnosis to prompt linkage to care and ART initiation: qualitative insights from coastal Kenya |
| Q37141323 | Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population. |
| Q30363755 | An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load |
| Q92538491 | An Inflammatory Story: Antibodies in Tuberculosis Comorbidities |
| Q35588077 | Anogenital HIV RNA in Thai men who have sex with men in Bangkok during acute HIV infection and after randomization to standard vs. intensified antiretroviral regimens |
| Q35619402 | Antibodies for prevention of mother-to-child transmission of HIV-1 |
| Q39108751 | Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development |
| Q37635041 | Antiretroviral therapy for the prevention of HIV transmission: what will it take? |
| Q42240556 | Antiretroviral therapy in primary HIV infection. |
| Q36930492 | Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation |
| Q34379806 | Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? |
| Q36836680 | Antiviral agents and HIV prevention: controversies, conflicts, and consensus |
| Q64060697 | Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy |
| Q38652389 | Application of nanodiagnostics in point-of-care tests for infectious diseases |
| Q91773467 | Are current guidelines adapted for patient eligibility to PrEP? A case report |
| Q40045943 | Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis |
| Q37117076 | Assessing willingness to test for HIV among men who have sex with men using conjoint analysis, evidence for uptake of the FDA-approved at-home HIV test |
| Q47169594 | B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection. |
| Q57180790 | British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 |
| Q35823144 | Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes |
| Q38811735 | Broadly neutralizing antibodies: An approach to control HIV-1 infection |
| Q34706934 | Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing |
| Q64098161 | Challenges of kidney transplantation in HIV positive recipients |
| Q34551274 | Changes in Natural Killer cell activation and function during primary HIV-1 Infection |
| Q36576582 | Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland |
| Q38686953 | Clinical and public health implications of acute and early HIV detection and treatment: a scoping review |
| Q35881546 | Community viral load as a measure for assessment of HIV treatment as prevention |
| Q34229245 | Complex population dynamics and the coalescent under neutrality |
| Q49762357 | Computational analysis of antibody dynamics identifies recent HIV-1 infection. |
| Q36972240 | Computational inference methods for selective sweeps arising in acute HIV infection |
| Q55421347 | Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection. |
| Q64068820 | Defining Kinetic Properties of HIV-Specific CD8⁺ T-Cell Responses in Acute Infection |
| Q41935990 | Depletion of gut-resident CCR5+ cells for HIV cure strategies |
| Q40594691 | Depression, Abuse, Relationship Power and Condom Use by Pregnant and Postpartum Women with Substance Abuse History. |
| Q54259081 | Design Strategy of the Sabes Study: Diagnosis and Treatment of Early HIV Infection Among Men Who Have Sex With Men and Transgender Women in Lima, Peru, 2013-2017. |
| Q36169234 | Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources |
| Q35868122 | Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test |
| Q33801473 | Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men |
| Q34535266 | Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses |
| Q37965692 | Diagnosing acute HIV infection |
| Q33725713 | Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice |
| Q34747521 | Diagnostic technologies in practice: gay men's narratives of acute or recent HIV infection diagnosis |
| Q40446044 | Differences in Risk Behavior and Demographic Factors Between Men Who Have Sex With Men With Acute and Nonacute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles |
| Q64997345 | Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection. |
| Q37273037 | Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa |
| Q34082628 | Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections |
| Q40040133 | Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation. |
| Q35896967 | Dynamic Variation in Sexual Contact Rates in a Cohort of HIV-Negative Gay Men. |
| Q36261775 | Dynamic changes in biomarkers in acute human immunodeficiency virus infections: a case report |
| Q36978926 | Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment. |
| Q35067151 | Early HIV infection in the United States: a virus's eye view |
| Q28534568 | Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study |
| Q35542113 | Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay |
| Q54942553 | Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review. |
| Q42645288 | Episodic HIV Risk Behavior Can Greatly Amplify HIV Prevalence and the Fraction of Transmissions from Acute HIV Infection |
| Q64231598 | Establishment of latent HIV-1 reservoirs: what do we really know? |
| Q64935340 | Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics. |
| Q41926717 | Estimating time of HIV-1 infection from next-generation sequence diversity |
| Q93089628 | Estimation of the Seroconversion Duration of HIV-1 Antibodies in Individuals With Recent Infection in China |
| Q47572010 | Evaluating the Evidence for More Frequent Than Annual HIV Screening of Gay, Bisexual, and Other Men Who Have Sex With Men in the United States: Results From a Systematic Review and CDC Expert Consultation |
| Q37109065 | Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya |
| Q39070368 | Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection |
| Q91675170 | Expansion of Stem Cell-Like CD4+ Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease Progression |
| Q35762863 | Experience in international clinical research: the HIV Prevention Trials Network |
| Q34310188 | Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection |
| Q26777569 | Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1: a systematic review |
| Q37412961 | Field immobilization for treatment of an unknown illness in a wild chimpanzee (Pan troglodytes schweinfurthii) at Gombe National Park, Tanzania: findings, challenges, and lessons learned |
| Q42705630 | First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection |
| Q40155276 | Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection |
| Q47582951 | Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice |
| Q36945699 | Future of phylogeny in HIV prevention |
| Q47560008 | Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings |
| Q40540897 | Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. |
| Q35831085 | Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants |
| Q90601603 | Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection |
| Q27014742 | Gut Microbiota in HIV Infection: Implication for Disease Progression and Management |
| Q27687375 | HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials |
| Q28607258 | HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice |
| Q46119171 | HIV and adolescents: focus on young key populations |
| Q34302303 | HIV delays IFN-α production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation |
| Q34662270 | HIV infection: epidemiology, pathogenesis, treatment, and prevention |
| Q28258739 | HIV preexposure prophylaxis: new data and potential use |
| Q42619001 | HIV prevention & treatment--reasons to rejoice & remain vigilant |
| Q30404963 | HIV prevention transformed: the new prevention research agenda |
| Q35077788 | HIV sexual transmission is predominantly driven by single individuals rather than discordant couples: a model-based approach |
| Q62489248 | HIV status disclosure during acute HIV infection in Malawi |
| Q35131212 | HIV testing and linkage to services for youth |
| Q41500321 | HIV testing updates and challenges: when regulatory caution and public health imperatives collide |
| Q36526615 | HIV transmission |
| Q41953810 | HIV transmissions by stage in dynamic sexual partnerships |
| Q34339450 | HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? |
| Q41655532 | HIV window period. Acute retroviral syndrome |
| Q40990807 | HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study |
| Q27022055 | HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design |
| Q36020074 | HIV-1 concentrations in human breast milk before and after weaning |
| Q36874604 | HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. |
| Q62488493 | HIV-1 transmission among persons with acute HIV-1 infection in Malawi: demographic, behavioral and phylogenetic relationships |
| Q28536682 | HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysis |
| Q37962420 | HIV/AIDS: 30 years of progress and future challenges. |
| Q43122061 | HPTN 052 and the future of HIV treatment and prevention |
| Q84565642 | HPTN 052 and the future of HIV treatment and prevention |
| Q36580019 | Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK |
| Q47139254 | Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection |
| Q47546880 | High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures |
| Q35072075 | High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection |
| Q59355914 | Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health |
| Q35814304 | How can we better identify early HIV infections? |
| Q64087572 | Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice |
| Q36171153 | Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin |
| Q39108760 | Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies. |
| Q90479619 | Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection |
| Q35571562 | Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation |
| Q34526026 | Impact of early-stage HIV transmission on treatment as prevention |
| Q26861475 | Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis |
| Q36576458 | Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi |
| Q47110966 | Increasing the Clinical Potential and Applications of Anti-HIV Antibodies |
| Q34629173 | Individualized diagnosis interventions can add significant effectiveness in reducing human immunodeficiency virus incidence among men who have sex with men: insights from Southern California |
| Q38170229 | Innate antiviral immune signaling, viral evasion and modulation by HIV-1. |
| Q38114912 | Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals |
| Q92978926 | Integrase strand-transfer inhibitors for treatment of early HIV infection: A case series |
| Q37423183 | Interferon-driven deletion of antiviral B cells at the onset of chronic infection. |
| Q56762706 | International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK |
| Q26860448 | Iron metabolism and the innate immune response to infection |
| Q40384151 | Knowledge and preferences concerning acute HIV testing programs among both Peruvian men who have sex with men and transgender women |
| Q47573139 | Knowledge, Normative Beliefs and Attitudes Related to Recent HIV Infection among People who Inject Drugs in Athens, Greece. |
| Q30490195 | Lessons from acute HIV infection |
| Q35585958 | Longitudinal changes in plasma Caspase-1 and Caspase-3 during the first 2 years of HIV-1 infection in CD4Low and CD4High patient groups |
| Q35928399 | Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. |
| Q36509593 | Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification |
| Q89830547 | Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials |
| Q34535113 | Measuring population transmission risk for HIV: an alternative metric of exposure risk in men who have sex with men (MSM) in the US. |
| Q37547462 | Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. |
| Q36377371 | Mediators of antiretroviral adherence: a multisite international study |
| Q35784803 | Medroxyprogesterone acetate impairs human dendritic cell activation and function |
| Q37037079 | Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus |
| Q28534497 | Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance |
| Q27022978 | Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells |
| Q37692346 | Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population |
| Q39419894 | Natural regulatory T cells inhibit production of cytotoxic molecules in CD8⁺ T cells during low-level Friend retrovirus infection |
| Q100490908 | Negative binomial mixed models for analyzing longitudinal CD4 count data |
| Q36725430 | Neurobehavioral Disturbances During Acute and Early HIV Infection |
| Q40274233 | New arrivals to New York City: vulnerability to HIV among urban migrant young gay men. |
| Q34220902 | No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial |
| Q34081339 | Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study |
| Q42231366 | Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses |
| Q22242661 | Origins of HIV and the AIDS pandemic |
| Q30249677 | Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. |
| Q37646636 | Pairwise diversity and tMRCA as potential markers for HIV infection recency |
| Q36353342 | Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission |
| Q36379702 | Perceived acceptability of home-based couples voluntary HIV counseling and testing in Northern Tanzania |
| Q36092039 | Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm |
| Q42270151 | Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection |
| Q30670919 | Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men. |
| Q38774793 | Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods Comparison. |
| Q37206422 | Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions |
| Q35055187 | Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients |
| Q46783117 | Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority |
| Q24635002 | Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals |
| Q36479690 | Population genomics of intrapatient HIV-1 evolution |
| Q42029259 | Possible transmission of human immunodeficiency virus-1 infection from an elite controller to a patient who progressed to acquired immunodeficiency syndrome: a case report |
| Q42367938 | Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection |
| Q33727042 | Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection |
| Q37619260 | Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries |
| Q55313111 | Prevalence of human immunodeficiency virus infection in brain glioma patients: Is the virus protective from gliomas? |
| Q61790657 | Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department |
| Q40051712 | Primary HIV Infection: Clinical Presentation, Testing, and Treatment |
| Q40731580 | Primary HIV infection: a medical and public health emergency requiring rapid specialist management |
| Q104468684 | Primary HIV-1 infection in users of pre-exposure prophylaxis |
| Q38574468 | Programmatic Implications of Acute and Early HIV Infection |
| Q35296597 | Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature |
| Q35732677 | Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques |
| Q37232818 | Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis |
| Q35828392 | Rationale and design of a randomized study of short-term food and cash assistance to improve adherence to antiretroviral therapy among food insecure HIV-infected adults in Tanzania |
| Q35188056 | Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts |
| Q34858876 | Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies |
| Q87405838 | Rectal microbicide development |
| Q64275866 | Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function |
| Q37056879 | Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort |
| Q38213061 | Role of Fc-mediated antibody function in protective immunity against HIV-1. |
| Q35189158 | Role of acute HIV infection in driving HIV transmission: implications for HIV treatment as prevention |
| Q39070385 | Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions. |
| Q37098390 | Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain |
| Q38812549 | Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING. |
| Q40169430 | Sexual partnership age pairings and risk of HIV acquisition in rural South Africa |
| Q36250347 | Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007. |
| Q34037516 | Short-course antiretroviral therapy in primary HIV infection |
| Q26826523 | Should we treat acute HIV infection? |
| Q94564167 | Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection |
| Q37732465 | Socially-integrated transdisciplinary HIV prevention. |
| Q28601386 | Sources of HIV infection among men having sex with men and implications for prevention |
| Q28539673 | Spatial epidemiology of recently acquired HIV infections across rural and urban areas of North Carolina |
| Q30277806 | Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests |
| Q26829461 | Structural insights on the role of antibodies in HIV-1 vaccine and therapy |
| Q40342272 | Sustained Reduction in Sexual Behavior that May Pose a Risk of HIV Transmission Following Diagnosis During Early HIV Infection Among Gay Men in Vancouver, British Columbia. |
| Q36468175 | Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa |
| Q42925387 | Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia |
| Q34576775 | Targeting the use of pooled HIV RNA screening to reduce cost in health department STD clinics: New York City, 2009-2011. |
| Q22242692 | Tenofovir-based pre-exposure prophylaxis for HIV prevention |
| Q35902684 | The HIV Epidemic: High-Income Countries. |
| Q37511883 | The Promise of Antiretrovirals for HIV Prevention |
| Q36854378 | The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. |
| Q33586581 | The detection and management of early HIV infection: a clinical and public health emergency |
| Q38849706 | The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion |
| Q34418077 | The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials |
| Q37524140 | The kidney as a reservoir for HIV-1 after renal transplantation |
| Q44038563 | The missing 27. |
| Q26851091 | The mucosal immune system in the oral cavity-an orchestra of T cell diversity |
| Q36195374 | The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care |
| Q38835962 | The network structure of sex partner meeting places reported by HIV-infected MSM: Opportunities for HIV targeted control. |
| Q90090236 | The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada |
| Q35742086 | The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study |
| Q24599103 | The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use |
| Q40619853 | The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression |
| Q39294118 | Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure |
| Q37610668 | Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention |
| Q34683831 | Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests |
| Q36982168 | Trends in the spectrum of engagement in HIV care and subsequent clinical outcomes among men who have sex with men (MSM) at a Boston community health center |
| Q33697163 | Tryptophan catabolism and immune activation in primary and chronic HIV infection |
| Q92681960 | Ubiquitination and SUMOylation in HIV Infection: Friends and Foes |
| Q36281395 | Ultrasensitive detection of HIV-1 p24 antigen by a hybrid nanomechanical-optoplasmonic platform with potential for detecting HIV-1 at first week after infection |
| Q34722424 | Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling study |
| Q37661224 | Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs |
| Q40064422 | Undiagnosed acute HIV infection identified through RNA testing of pooled serum samples obtained during a dengue outbreak in São Paulo, Brazil |
| Q38209874 | Update on antiretroviral treatment during primary HIV infection |
| Q36786153 | Using a Mobile Health Intervention to Support HIV Treatment Adherence and Retention Among Patients at Risk for Disengaging with Care |
| Q92150069 | Vertical transmission of HIV among pregnant women who initially had false-negative rapid HIV tests in four South African antenatal clinics |
| Q21045423 | Viral Phylodynamics |
| Q37112617 | Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis |
| Q34040248 | Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective |
| Q35943537 | Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection |
| Q54264283 | Vitamin D serum levels and receptor genetic polymorphisms are associated with hepatitis B virus and HIV infections and IFN-λ levels. |
| Q34526461 | Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence |
| Q91822695 | [Dolutegravir in acute HIV-1 infection: first reported case] |
| Q57150995 | p24 revisited: a landscape review of antigen detection for early HIV diagnosis |
Search more.